IL17REL
Interleukin-17 receptor E-like protein
Also known as: I17EL_HUMAN
Protein identityUniProt · HPA
- UniProt accession
- Q6ZVW7
- Gene
- IL17REL
- Canonical length
- 507 aa
- Protein class
- Predicted intracellular proteins
OverviewNCBI Gene
No narrative summary is available for IL17REL in this catalog release; identity and structured annotations are shown without generated factual claims.
Canonical amino-acid sequenceUniProt
507 residues, UniProt reviewed canonical sequence.
>Q6ZVW7|IL17REL
1 MLAGQALAFL GLTWGTFQSL AIPRITECGL SCSQGFACRS HRNRNIFNSF CRPRPVSMSR
61 SVLEALTSST AMQCVPSDGC AMLLRVRASI TLHERLRGLE ACAMSLDTQE TQCQSVWVAR
121 ASHRQQGGQQ LQVHFGCFAV SVAQHLYVTL RTIPHFCGVQ LDQRHLVEDC GEEDVGRSVP
181 DCLAGKLSYW VDRRRKAILV QVPRASGSPD YYLRLCLKRF TCEDAGAPVR VTANSVSQAV
241 FLPYSQELPC LCLEGWSATP DAVRIQICPF ENDTEALEVL WDTVYYHPES QTLSWEPACP
301 VSGHVSLCWR PGPGAGCRKL QQSSQLVHRR VQYPLVDTQP QLCLKFSTSW GSWVRCPFEQ
361 RRFPTWKMTI QPSPTKGHLR VTFFSSSPAH FQVHLCHRRK SQLPACQRTL QASPLPSASG
421 DLAAAPAFAF LDLPREEACA PGICIQGWRT DVHFSVPQQL CNLRSSGCPS LRGRRRPRTR
481 PRPPTAGWAW RALNRRLGGG NGETIRPLocalizationUniProt · AlphaFold · HPA
Whether an antibody against IL17REL can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.36
- Highest tissue expression
- 4 nTPM
Expression across tissuesHPA
Tissue
- tonsil: 4 nTPM
- thymus: 3.2 nTPM
- appendix: 2.1 nTPM
- lymph node: 1.9 nTPM
- stomach: 1.7 nTPM
- spleen: 0.8 nTPM
Single-cell type
- epicardial cells: 34 nCPM
- foveolar cells: 23 nCPM
- endometrial luminal cells: 23 nCPM
- endometrial secretory cells: 14 nCPM
- endometrial glandular cells: 14 nCPM
- goblet cells: 5.9 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- hypothalamus: 2.9 nTPM
- cerebral cortex: 2 nTPM
- pons: 1.7 nTPM
- white matter: 1.5 nTPM
- midbrain: 1.4 nTPM
- thalamus: 1.4 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.72
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.29
- DepMap mean gene effect
- 0.04
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads IL17REL as an antibody target. Whether an autoantibody or antibody against IL17REL could matter depends on whether native IL17REL is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
IL17REL is annotated as secreted, so native IL17REL circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label IL17REL as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...